Edition:
United States

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

121.13USD
17 Aug 2018
Change (% chg)

$0.54 (+0.45%)
Prev Close
$120.59
Open
$120.58
Day's High
$121.52
Day's Low
$120.43
Volume
77,588
Avg. Vol
87,236
52-wk High
$130.66
52-wk Low
$96.70

Chart for

About

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its... (more)

Overall

Beta: 0.67
Market Cap(Mil.): $5,803.56
Shares Outstanding(Mil.): 47.91
Dividend: --
Yield (%): --

Financials

  CRL.N Industry Sector
P/E (TTM): 28.47 99.36 30.45
EPS (TTM): 4.25 -- --
ROI: 7.37 2.89 12.63
ROE: 19.21 1.65 14.82

BRIEF-Charles River Laboratories Announces First-Quarter 2018 Results From Continuing Operations

May 10 Charles River Laboratories International Inc:

May 10 2018

BRIEF-Charles River Laboratories Reports Q1 Non-GAAP Earnings Per Share Of $1.38

May 10 Charles River Laboratories International Inc:

May 10 2018

BRIEF-Charles River Laboratories CEO's 2017 Total Compensation Was $12.6 Mln

March 29 Charles River Laboratories International Inc:

Mar 29 2018

BRIEF-Charles River Laboratories Announces Offering Of $500 Mln Of Senior Notes

March 26 Charles River Laboratories International Inc:

Mar 26 2018

Earnings vs. Estimates